Miyahara, Sachiko <br/><br/>
Applying a Risk-benefit Analysis to Outcomes in Tuberculosis Clinical Trials.  [electronic resource] 

 -  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America  02 2020 
 - 698-703 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1537-6591 
<br/><br/><label>Standard No.: </label>10.1093/cid/ciz784  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antitubercular Agents--therapeutic use<br/>Clinical Trials as Topic<br/>Humans<br/>Isoniazid<br/>Risk Assessment<br/>Tuberculosis--drug therapy